FDA Investigator Thomas A Peter

Thomas A Peter has inspections in 17 countries as of 31 Aug 2023. Thomas A Peter has collaborated with a combinined 3943 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
100
Last Inspection Date:
31 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, France, Italy, China, Canada, Germany, Malaysia, Taiwan, United Kingdom of Great Britain and Northern Ireland, Switzerland, Belgium, Japan, Sweden, Brazil, Australia, Singapore
Co-Investigator(s):
A Williams, Adaliz Santaliz Cruz, Ademola O Daramola, Alberto Gutierrez, PhD, Alexandra A Carrico, Amy S Graf, Anjali Shukla, PhD, Anthony R Petriella, Armando Morales, Art O Czabaniuk, Azza Talaat, Bei Y He, Benjamin J Dastoli, Benjamin J Smith, Bleta Vuniqi, Brentley S Collins, Brian J Mundo, Brian M Campbell, Brian M Marosan, Brian P Putz, Bruce H Mccullough, Bryan J Love, Calvin K Cook, Carolyn J Oyster, Catherine J Laufmann, Catherine V Quinlan, CDR Sean T Creighton, Cecelia G Vincent, Charles I Ann, Charles L Larson, Charles M Spyr, Cheryl A Fuhs, Cheryl D Mccall, Cheryl E English, Christian D Lynch (CDL), Christina L Bigham, Christine I Shaw, Christopher S Genther, Christopher T Middendorf, Cynthia A Harris, MD, RN, Cynthia J Lee, MS, Cynthia Jim, CSO, Cynthia L Aycock, Cynthia Li, Cynthia M Goudeau, Danial S Hutchison, Daniel J Brown, Daniel J Lahar, Darren S Morgan, David J Gasparovich, David J Gsparovich, David M Beltran, Dawn C Olenjack, Deanna L Lampley, Debara R Reese, Dell S Moller, Dennis R Hock, Don H Bark, PhD, Dwayne W Jarman, Edmund F Mrak, Jr, Eliezar Ramos, Elizabeth B Griffin, Emilie E Kahn, Emily J Orban, Eric E Joneson, Eric S Pittman, Felicia E Hinojosa, Felix J Marrero, Francis J Eng, Frank J Marciniak, French, Gary Durbiel Goldner, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, George G Calafactor, Gwyn G Dickinson, Harperd, Hartman, Helen B Ricalde, Hokenson, Ian A Pilcher, Iris C Macinnes, Jacob A Clark, Jacob G Lutz, Jacqueline Mdiaz Albertini, James D Hildreth, James E Szelc, James K Ireland, James W Whitney, Janet L Bowen, Javonica F Penn, Jeene D Bailey, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey W Shrifter, DPM, Jesse A Vazquez, Jessica L Johnson, John A Sciacchitano, Joseph R Strelnik, Kalavati Suvarna, PhD, Kathryn A Guardiola, Kathryn G Brown, Kathryn M Blackshear, Kelly D Sheppard, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Kim Lthomas Cruse, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina Fillmore, Kristina Nastovski, Laureen F Kononen, Laureen M Geniusz, Lauren E Burke, Lauren E Priest, Lauren E Sexton, LCDR Anastasia Mpiliafas Brown, LCDR Debra Emerson, Leslie A Paul, Leslie R Clark, Linda M Cheny, Linda S Jozefiak, Lisa M Thursam, Lori A Carr, Lori A Medina, Lori S Lawless, LT Skip A Payne, LTJG Aaron B Otis, Margaret N Persich, Maribeth G Niesen, Marlon K Turner, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Mei Chiung J Huang, Melanie W Pishnery, Michael A Charles, Michael A Moutray, Michael K Larson, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Monica L Hughes, Myra K Casey, Nancy A Bellamy, Nicholas L Paulin, Owens, Paige E Shelborne, Patrick B Cummings, Patsy I Domingo, Patsy J Domingo, Paul W Moy, Paula A Trost, Philip A Klimkewicz, Phillip M Pontikos, Prabhu P Raju, Preston M Lee, Ralph A Erickson, Randy L Self, Rasha Bamieh, Raymond R Roy, PhD, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Richard Jay Tucker, RS, Richard K Vogel, Richard L Rutherford, Robert C Coleman, Robert M Barbosa, Robert P Whisenant, Robert R Barbosa, Roger A Hartman, Ronald G Crawford, Rosanna M Goodrich, Ryan J Benedict, Sanket N Patel, Sarah E Rhoades, Sarah Forney, Sarah M Napier, Sargum C Manley, Sargum C Sood, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott C Gonzalez, Seema S Singh, Seneca D Toms, Sergio Chavez (NMI), Shannon A Gregory, Shawn R Gould, Sidney B Priesmeyer, State Agency, Stephen D Eich, Susan M Jackson, Susan P Bruederle, Suyang Qin, Talmane J Fisher, Teresa K Kastner, Thomas E Friel, Thomas J Cosgrove, Timothy A Riles, Tonnie L Carter, Tracey Asinjen Wiersma, Tracey L Siebesma, Travis S Bradley, Twana R Chandler, Tyra L Vanleer, Vesa Vuniqi, Vlada Matusovsky, Wayne E Seifert, Wendy M Stark, William D Tingley, William R Brubaker, Xiaojun Yan, Xiaokuang Lai, PhD, Yvette Mlacour Davis, Zhong Li, PhD

Thomas A Peter's Documents

Publish Date Document Type Title
February, 2017 FDA 483 Pacific Hospital Supply Co., Ltd. - Form 483, 2017-02-22
June, 2013 FDA 483 Response Zimmer, Inc. - Form 483R, 2014-05-28
April, 2023 FDA 483 CXMedUS, Inc. - Form 483, 2023-04-06
June, 2013 EIR Zimmer, Inc. - EIR, 2013-06-20
October, 2018 FDA 483 Specialty Manufacturing, Inc. - Form 483, 2018-10-25
May, 2014 FDA 483 Zimmer, Inc. - Form 483, 2014-05-28
November, 2015 FDA 483 Zimmer, Inc. - Form 483, 2015-11-20
November, 2019 FDA 483 Centurion Medical Products, LP - Form 483, 2019-11-01
June, 2014 EIR Biomet, Inc. - EIR, 2014-06-30
December, 2017 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2017-12-22
December, 2010 FDA 483 Troy Biologicals, Inc. - Form 483, 2010-12-29
September, 2012 FDA 483 Response Terumo Cardiovascular Systems Corporation - Form 483R, 2012-10-19
August, 2015 EIR Richard-Allan Scientific Company - EIR, 2015-08-26
February, 2019 FDA 483 CEP Bio-Coat, LLC - Form 483, 2019-02-15
January, 2015 FDA 483 Allergan Industrie SAS - Form 483, 2015-01-29
December, 2012 FDA 483 Excel Medical Products, Inc. - Form 483, 2012-12-21
December, 2017 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2018-01-17
October, 2019 EIR Oxus, Inc. - EIR, 2019-10-20
October, 2019 FDA 483 Oxus, Inc. - Form 483, 2019-10-10
October, 2021 FDA 483 Materialise USA LLC - Form 483, 2021-10-06
January, 2023 FDA 483 Stryker Corporation - Form 483, 2023-01-24
September, 2020 FDA 483 CEP Bio-Coat, LLC - Form 483, 2020-09-29
August, 2014 FDA 483 Signal Medical Corporation - Form 483, 2014-08-11
May, 2012 FDA 483 Xoran Technologies, LLC - Form 483, 2012-05-24
November, 2011 FDA 483 JosNoe Medical, Inc. - Form 483, 2011-11-29
November, 2016 FDA 483 Response Biomet, Inc. - Form 483R, 2016-12-21
January, 2016 FDA 483 King Brand Healthcare Products Ltd. - Form 483, 2016-01-21
July, 2018 FDA 483 Omega Plastics Inc. - Form 483, 2018-07-20
January, 2020 FDA 483 Biomet, Inc. - Form 483, 2020-01-30
November, 2015 FDA 483 Response Zimmer, Inc. - Form 483R, 2015-12-21
July, 2011 FDA 483 Zimmer, Inc. - Form 483, 2011-07-22
November, 2013 FDA 483 Excel Medical Products, Inc. - Form 483, 2013-11-13
February, 2018 FDA 483 Maquet SAS - Form 483, 2018-02-01
June, 2014 FDA 483 Response Biomet, Inc. - Form 483R, 2014-07-21
November, 2019 FDA 483 Centurion Medical Products, LP - Form 483, 2019-08-20
April, 2018 FDA 483 Biomet, Inc. - Form 483, 2018-04-24
December, 2018 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2018-12-10
September, 2020 FDA 483 Response CEP Bio-Coat, LLC - Form 483R, 2020-12-09
August, 2023 FDA 483 O3UV, LLC - Form 483, 2023-09-21
February, 2018 FDA 483 STERIS Deutschland GmbH - Form 483, 2018-02-08
July, 2012 FDA 483 Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc. - Form 483, 2012-07-20
February, 2012 FDA 483 3T Medical Systems, LLC - Form 483, 2012-02-17
March, 2015 FDA 483 Beijing KES Biology Technology Co., Ltd. - Form 483, 2015-03-20
February, 2014 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2014-02-17
June, 2013 FDA 483 Zimmer, Inc. - Form 483, 2013-06-20
November, 2017 FDA 483 Response Unique Instruments, Inc. - Form 483R, 2017-11-21
April, 2011 FDA 483 Signal Medical Corporation - Form 483, 2011-04-26
December, 2010 FDA 483 Pioneer Surgical Technology Inc. - Form 483, 2010-12-21
June, 2014 FDA 483 Biomet, Inc. - Form 483, 2014-06-30
April, 2018 FDA 483 Response Biomet, Inc. - Form 483R, 2018-05-15
November, 2017 FDA 483 Unique Instruments, Inc. - Form 483, 2017-11-01
May, 2015 FDA 483 Sterilin Limited - Form 483, 2015-05-01
July, 2015 FDA 483 Sagami Manufacturers Sdn. Bhd. - Form 483, 2015-07-02
April, 2019 FDA 483 Petoskey Plastics, Inc. - Form 483, 2019-04-10
September, 2012 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2012-09-28
November, 2014 FDA 483 BioPro, Inc. - Form 483, 2014-12-02
February, 2015 FDA 483 BTS S.p.A. - Form 483, 2015-02-05
October, 2022 FDA 483 CEP Bio-Coat, LLC - Form 483, 2022-10-12
November, 2016 FDA 483 Biomet, Inc. - Form 483, 2016-11-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more